AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Structure Therapeutics Inc. American Depositary Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG01CBVHMQ6
21.19▼ 0.74 (-3.37%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
21.93
Day's Range
21.13 – 21.97
52-Week Range
20.73 – 94.90
Volume
795.1K
Avg Volume
1.2M
Share Statistics
Shares Outstanding
Employees
220
Exchange
XNAS
Listed
2023-02-03
Share count as of July 31, 2026

Structure Therapeutics Inc. American Depositary Shares (GPCR) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Structure Therapeutics Inc. American Depositary Shares (GPCR)
What is Structure Therapeutics Inc. American Depositary Shares's Market Cap?
Structure Therapeutics Inc. American Depositary Shares's Market Cap is $4.5B, based on as-reported figures from SEC (XBRL) filings.
What is Structure Therapeutics Inc. American Depositary Shares's Enterprise Value?
Structure Therapeutics Inc. American Depositary Shares's Enterprise Value is $3.2B, based on as-reported figures from SEC (XBRL) filings.
What is Structure Therapeutics Inc. American Depositary Shares's EV / EBITDA?
Structure Therapeutics Inc. American Depositary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Structure Therapeutics Inc. American Depositary Shares's Net Income (TTM)?
Structure Therapeutics Inc. American Depositary Shares's Net Income (TTM) is -$214.8M, based on as-reported figures from SEC (XBRL) filings.
What is Structure Therapeutics Inc. American Depositary Shares's EBITDA?
Structure Therapeutics Inc. American Depositary Shares's EBITDA is -$255.9M, based on as-reported figures from SEC (XBRL) filings.
What is Structure Therapeutics Inc. American Depositary Shares's Diluted EPS (TTM)?
Structure Therapeutics Inc. American Depositary Shares's Diluted EPS (TTM) is -1.00, based on as-reported figures from SEC (XBRL) filings.
What is Structure Therapeutics Inc. American Depositary Shares's Net Debt?
Structure Therapeutics Inc. American Depositary Shares's Net Debt is -$1.3B, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · GPCRAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Interest and other income, net
Loss before provision for income taxes
Provision for income taxes
Net loss attributable to ordinary shareholders
Net loss per share attributable to ordinary shareholders, basic (in dollars per share)
Net loss per share attributable to ordinary shareholders, diluted (in dollars per share)